Diffusion Magnetic Resonance Imaging in Multiple Sclerosis

Neuroimaging Clinics of North America

Volumn 21, Issue 1, 2011, Pages 71-88

  Hygino da Cruz, L Celso ^a,b,c   Batista, Raquel Ribeiro ^d   Domingues, Roberto Cortes ^a   Barkhof, Frederik ^e  

^a CDPI and Multi Imagem Clinics   (Brazil)

^b Clinic IRM   (Brazil)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d CDPI Clinic   (Brazil)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Central nervous system; Diffusion MR imaging; Multiple sclerosis; Plaques

Indexed keywords

CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CORRELATION ANALYSIS; DIFFUSION WEIGHTED IMAGING; GRAY MATTER; HUMAN; MULTIPLE SCLEROSIS; OPTIC NERVE; PRIORITY JOURNAL; REVIEW; SPINAL CORD; TRACTOGRAPHY; WHITE MATTER;

ADULT; AGE FACTORS; BRAIN; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MULTIPLE SCLEROSIS; OPTIC NERVE; SPINAL CORD; YOUNG ADULT;

EID: 79953314794     PISSN: 10525149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nic.2011.02.006     Document Type: Review

References (109)

1. Rodriguez M., Silva A., Ward J., et al. Impairment, disability and handicap in multiple sclerosis: a population-based study in Olmsted Country, Minnesota. Neurology 1994, 44:28-33.
2. Inglese M. Multiple sclerosis: new insights and trends. AJNR Am J Neuroradiol 2006, 27:954-957.
3. Nusbaum A.O., Rapalino O., Fung K., et al. White matter diseases and inherited metabolic disorders. Magnetic resonance imaging of the brain and spine 2009, 343-444. Lippincott Williams & Wilkins, Philadelphia. 4th edition. S. Atlas (Ed.).
4. Young I.R., Hall A.S., Pallis C.A., et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981, 2(8255):1063-1066.
5. Ge Y. Multiple sclerosis: the role of MR imaging. AJNR Am J Neuroradiol 2006, 27:1165-1176.
6. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001, 50:121-127.
7. Barkhof F., Filippi M., Miller D.H., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definitive multiple sclerosis. Brain 1997, 120:2059-2069.
8. Tintore M., Rovira A., Martinez M.J., et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definitive multiple sclerosis. AJNR Am J Neuroradiol 2000, 21:702-706.
9. Polman C.H., Reingold S.C., Edan G., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the " McDonald Criteria" Ann Neurol 2005, 58:840-846.
10. Zwemmer J.N., Bot J.C., Jelles B., et al. At the heart of primary progressive multiple sclerosis: three cases with diffuse MRI abnormalities only. Mult Scler 2008, 14:428-430.
11. Warach S., Chien D., Li W., et al. Fast magnetic resonance diffusion-weighted imaging of acute human stroke. Neurology 1992, 42:1717-1723.
12. Cruz L.C., Souensen A.G. Diffusion tensor magnetic resonance imaging of brain tumors. Neurosurg Clin N Am 2005, 16:115-134.
13. Guo A.C., Provenzale J.M., Cruz L.C., et al. Cerebral abscesses: investigation using apparent diffusion coefficient maps. Neuroradiology 2001, 43:370-374.
14. Parente D.B., Gasparetto E.L., Cruz L.C., et al. Potential role of diffusion tensor MRI in the differential diagnosis of mild cognitive impairment and Alzheimer's disease. AJR Am J Roentgenol 2008, 190:1369-1374.
15. Rovaris M., Gass A., Bammer R., et al. Diffusion MRI in multiple sclerosis. Neurology 2005, 65:1526-1532.
16. Cruz L.C., Domingues R.C., Gasparetto E.L. Diffusion tensor imaging of the cervical spinal cord of patients with relapsing-remising multiple sclerosis: a study of 41 cases. Arq Neuropsiquiatr 2009, 67:391-395.
17. Rueda F., Cruz L.C., Domingues R.C., et al. Diffusion tensor MR imaging evaluation of the corpus callosum of patients with multiple sclerosis. Arq Neuropsiquiatr 2008, 66:449-453.
18. Holodny A.I., Ollenschlager M. Diffusion imaging in brain tumor. Neuroimaging Clin N Am 2002, 12:107-124.
19. Stejskal E., Tanner J. Spin diffusion measurements: spin echoes in the presence of time-dependent field gradient. J Chem Phys 1965, 42:288-292.
20. Romero J.M., Schaefer P.W., Grant P.E., et al. Diffusion MR imaging of acute ischemic stroke. Neuroimaging Clin N Am 2002, 12:35-53.
21. Pagani E., Hirsch J.G., Pouwels P.J., et al. Intercenter differences in diffusion tensor MRI acquisition. J Magn Reson Imaging 2010, 31:1458-1468.
22. Le Bihan D., Mangin J.F., Poupon C., et al. Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 2001, 13:534-546.
23. Pierpaoli C., Jezzard P., Baser P.J., et al. Diffusion tensor MR imaging of the human brain. Radiology 1996, 201:637-648.
24. Basser P.J., Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor-MRI. J Magn Reson B 1996, 111:209-219.
25. Melhem E.R., Mori S., Mukundan G., et al. Diffusion tensor MR imaging of the brain and the white matter tractography. AJR Am J Roentgenol 2002, 178(1):3-16.
26. Ito R., Mori S., Melhem E.R. Diffusion tensor MR imaging and tractography. Neuroimaging Clin N Am 2002, 12(1):1-19.
27. Castriota-Scanderbeg A., Tomaiuolo F., Sabatini U., et al. Demyelinating plaques in relapsing-remitting and secondary-progressive multiple sclerosis: assessment with diffusion MR imaging. AJNR Am J Neuroradiol 2000, 21:862-868.
28. van Walderveen M.A., Barkhof F., Hommes O.R., et al. Correlating MRI and clinical disease activity in multiple sclerosis: relevance of hypointense lesions on short-TR/short-TE (T1-weighted) spin-echo images. Neurology 1995, 45:1684-1690.
29. Truyen L., van Waesberghe J.H., van Walderveen M.A., et al. Accumulation of hypointense lesions (" black holes" ) on T1 spin-echo MRI correlates with disease progression in multiple sclerosis. Neurology 1996, 47:1469-1476.
30. Grossman R.I., Braffman B.H., Brorson J.R., et al. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging. Radiology 1998, 169:117-122.
31. Barkhof F., Scheltens P., Frequin S.T., et al. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity. AJR Am J Roentgenol 1992, 159:1041-1047.
32. Horsfield M.A., Larsson H.B., Jones D.K., et al. Diffusion magnetic resonance imaging in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998, 64(Suppl 1):S80-S84.
33. Barnes D., Munro P.M., Youl B.D., et al. The longstanding multiple sclerosis lesion: a quantitative MRI and electron microscopic study. Brain 1991, 114:1271-1280.
34. Roychowdhury S., Maldjian J.A., Grossman R.I. Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. AJNR Am J Neuroradiol 2000, 21:869-874.
35. van Waesberghe J.H., van Walderveen M.A., Castelijns J.A., et al. Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol 1998, 19:675-683.
36. Bammer R., Augustin M., Strasser-Fuchs S., et al. Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis. Magn Reson Med 2000, 44:583-591.
37. Filippi M., Inglese M. Overview of diffusion-weighted magnetic resonance studies in multiple sclerosis. J Neurol Sci 2001, 186(Suppl 1):S37-S43.
38. Filippi M., Cercignani M., Inglese M., et al. Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology 2001, 56:304-311.
39. Filippi M., Iannucci G., Cercignani M., et al. A quantification study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging. Arch Neurol 2000, 57:1017-1021.
40. Castriota-Scanderbeg A., Sabatini U., Fasano F., et al. Diffusion of water in large demyelinating lesions: a follow-up study. Neuroradiology 2002, 44:764-767.
41. Rovaris M., Agosta F., Pagani E., et al. Diffusion tensor MR imaging. Neuroimaging Clin N Am 2009, 19:37-43.
42. Song S.K., Sun S.W., Ramsbottom M.J., et al. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002, 17:1429-1436.
43. DeBoy C.A., Zhang J., Dike S., et al. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain 2007, 130:2199-2210.
44. Song S.K., Yoshino J., Le T.Q., et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005, 26:132-140.
45. Gasparetto E, Rueda F, Cruz Jr LC, et al. Acute and chronic demyelinating plaques in patients with multiple sclerosis: a diffusion tensor magnetic resonance imaging study. Paper presented at: RSNA Scientific Assembly and Annual Meeting. Chicago, November 30 to December 3, 2008.
46. Kealey S.M., Kim Y., Whiting W.L., et al. Determination of multiple sclerosis plaque size with diffusion-tensor MR imaging: comparison study with healthy volunteers. Radiology 2005, 236(2):615-620.
47. Filippi M., Horsfield M.A., Hajnal J.V., et al. Quantitative assessment of magnetic resonance imaging lesion load in multiple sclerosis. J Neurol Neurosurg Psychiatry 1998, 64(Suppl 1):S88-S93.
48. Kalkers N.F., Bergers E., Castelijns J.A., et al. Optimizing the association between disability and biological markers in MS. Neurology 2001, 57:1253-1258.
49. Bozzali M., Cercignani M., Sormani M.P., et al. Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol 2002, 23:985-988.
50. Trapp B.D., Ransohoff R., Rudick R. Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 1999, 12:295-302.
51. Camp S.J., Stevenson V.L., Thompson A.J., et al. Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates. Brain 1999, 122:1341-1348.
52. Rovaris M., Judica E., Ceccarelli A., et al. A 3-year diffusion tensor MRI study of grey matter damage progression during earliest clinical stage of MS. J Neurol 2008, 255:1209-1214.
53. Pulizzi A., Rovaris M., Judica E., et al. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Arch Neurol 2007, 64:1163-1168.
54. Rovaris M., Riccitelli G., Judica E., et al. Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology 2008, 71:1521-1526.
55. Ciccarelli O., Werring D.J., Wheeler-Kingshott C.A., et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001, 56:926-933.
56. Mainero C., De Stefano N., Iannucci G., et al. Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology 2001, 56:1331-1334.
57. Lucchinetti C.F., Bruck W., Rodriguez M., et al. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol 1996, 6:259-274.
58. Guo A.C., MacFall J.R., Provenzale J.M. Multiple sclerosis: diffusion tensor MR imaging for evaluation of normal-appearing white matter. Radiology 2002, 222:729-736.
59. Rocca M.A., Cercignani M., Iannucci G., et al. Weekly diffusion-weighted imaging of normal-appearing white matter in MS. Neurology 2000, 55:882-884.
60. Griffin C.M., Chard D.T., Ciccarelli O., et al. Diffusion tensor imaging in early relapsing-remitting multiple sclerosis. Mult Scler 2001, 7:290-297.
61. Rachid W., Hadjiprocopis A., Griffin C.M., et al. Diffusion tensor imaging of early relapsing-remitting multiple sclerosis with histogram analysis using automated segmentation and brain volume correction. Mult Scler 2004, 10:9-15.
62. Gallo A., Rovaris M., Riva R., et al. Diffusion tensor MRI detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earlier stage of multiple sclerosis. Arch Neurol 2005, 62:803-808.
63. Ge Y., Law M., Johnson G., et al. Preferential occult corpus callosum in multiple sclerosis measured by diffusion tensor imaging. J Magn Reson Imaging 2004, 20:1-7.
64. Ciccarelli O., Werring D.J., Barker G.J., et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging: evidence of Wallerian degeneration. J Neurol 2003, 250:287-292.
65. Evangelou N., Esiri M.M., Smith S., et al. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000, 47:391-395.
66. Peterson J.W., Bo L., Morks S., et al. Transected neuritis, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001, 50:389-400.
67. Kidd D., Barkhof F., McConnell R., et al. Cortical lesions in multiple sclerosis. Brain 1999, 122:17-26.
68. Bo L., Vedeler C.A., Nyland H., et al. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003, 9:323-331.
69. McKinstry R.C., Mathur A., Miller J.H., et al. Radial organization of developing preterm human cerebral cortex revealed by non-invasive water diffusion anisotropy MRI. Cereb Cortex 2002, 12:1237-1243.
70. Wegner C., Esiri M.M., Chance S.A., et al. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006, 67:960-967.
71. Cercignani M., Bozzali M., Iannucci G., et al. Magnetization transfer and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry 2001, 70:311-317.
72. Pouwels P.J., Kuijer J.P., Mugler J.P., et al. Human gray matter: feasibility of single-slab 3D double inversion-recovery high-spatial-resolution MR imaging. Radiology 2006, 241:873-879.
73. Hou P., Hasan K.M., Sitton C.W., et al. Phase-sensitive T1 inversion recovery imaging: a time-efficient interleaved technique for improved tissue contrast in neuroimaging. AJNR Am J Neuroradiol 2005, 26:1432-1438.
74. Jezzard P., Barnett A.S., Pierpaoli C. Characterization of and correction for eddy current artifacts in echo planar diffusion imaging. Magn Reson Med 1998, 39:801-812.
75. Rovaris M., Iannucci G., Falautano M., et al. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci 2002, 195:103-109.
76. Vreken H., Pouwels P.J., Geurts J.J., et al. Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion changes seem related to clinical deterioration. J Magn Reson Imaging 2006, 23:628-636.
77. Poonawalla A.H., Hasan K.M., Gupta R.K., et al. Diffusion-tensor MR imaging of cortical lesions in multiple sclerosis: initial findings. Radiology 2008, 246(3):880-886.
78. Heaton R.H., Nelson L.M., Thompson D.S., et al. Neuropsychological findings in relapsing remitting and chronic progressive multiple sclerosis. J Consult Clin Psychol 1985, 53:103-110.
79. Fisher E., Lee J.C., Nakamura K., et al. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008, 64:255-265.
80. Arnold A.C. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol 2005, 139:1101-1108.
81. Glisson C.C., Galetta S.L. Nonconventional optic nerve imaging in multiple sclerosis. Neuroimaging Clin N Am 2009, 19:71-79.
82. Hickman S.J., Wheeler-Kingshott C.A., Jones S.J., et al. Optic nerve diffusion measurement from diffusion weighted imaging in optic neuritis. AJNR Am J Neuroradiol 2005, 26:951-956.
83. Anand Trip S., Wheeler-Kingshott C.A., Jones S.J., et al. Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage 2006, 30:498-505.
84. Ciccarelli O., Toosy A.T., Hickman S.J., et al. Optic radiation changes after optic neuritis detected by tractography-based group mapping. Hum Brain Mapp 2005, 25:308-316.
85. Chitnis T. Pediatric multiple sclerosis. Neurologist 2006, 12:299-310.
86. Chitnis T., Glanz B., Jaffin S., et al. Demographics of pediatric-onset multiple sclerosis in a MS center population from the Northeastern United States. Mult Scler 2009, 15:627-631.
87. Simone I.L., Carrara D., Tortorella C., et al. Course and prognosis in early-onset MS: comparison with adult-onset forms. Neurology 2002, 59:1922-1928.
88. Gorman M.P., Healy B.C., Polgar-Turcsanyi M., et al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009, 66:54-59.
89. Mezzapesa D.M., Rocca M.A., Falini A., et al. A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. Arch Neurol 2004, 61:366-368.
90. Tortorella C., Rocca M.A., Mezzapesa D., et al. MRI quantification of gray and white matter damage in patients with early-onset multiple sclerosis. J Neurol 2006, 253:903-907.
91. Vishwas M.S., Chitnis T., Pienaar R., et al. Tract-based analysis of callosal, projection, and association pathways in pediatric patients with multiple sclerosis: a preliminary study. AJNR Am J Neuroradiol 2010, 31:121-128.
92. Basser P.J., Pajevic S., Pierpaoli C., et al. In vivo fiber tractography using DT-MRI data. Magn Reson Med 2000, 44:625-632.
93. Jones D.K. Determining and visualizing uncertainty in estimates of fiber orientation from diffusion tensor MRI. Magn Reson Med 2003, 49:7-12.
94. Ge Y., Tuvia K., Law M., et al. Corticospinal tract degeneration in brainstem in patients with multiple sclerosis: evaluation with diffusion tensor tractography. Int Soc Magn Reson Med 2005, 394.
95. Soohoo S, Ge Y, Law M, et al. Lesional fractional anisotropy, diffusivity and fiber tractography in patient with multiple sclerosis with DTI at 3 Tesla. In: Proceedings of the 43rd Annual Meeting of the American Society of Neuroradiology. Toronto; 2005. p. 108.
96. Trapp B.D., Peterson J., Ransohoff R.M., et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998, 338:278-285.
97. Wilson M., Tench C.R., Morgan P.S., et al. Pyramidal tract mapping by diffusion tensor magnetic resonance imaging in multiple sclerosis: improving correlations with disability. J Neurol Neurosurg Psychiatry 2003, 74:203-207.
98. Pagani E., Filippi M., Rocca M.A., et al. A method for obtaining tract-specific diffusion tensor MRI measurements in the presence of disease: application to patient with clinically isolated syndromes suggestive of multiple sclerosis. Neuroimage 2005, 26:258-265.
99. Lin F., Yu C., Jiang T., et al. Diffusion tensor tractography-based group mapping of pyramidal tract in relapsing-remitting multiple sclerosis patients. AJNR Am J Neuroradiol 2007, 28:278-282.
100. Kollia K., Maderwald S., Putzki N., et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR Am J Neuroradiol 2009, 30:699-702.
101. Keiper M.D., Grossman R.I., Hirsch J.A., et al. MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5T and 4T. AJNR Am J Neuroradiol 1998, 19:1489-1493.
102. Tan I.L., van Shijndel R.A., Pouwels P.J., et al. MR venography of multiple sclerosis. AJNR Am J Neuroradiol 2000, 21:1039-1042.
103. Pagani E., Bammer R., Horsfield M.A., et al. Diffusion MRI in multiple sclerosis: technical aspects and challenges. AJNR Am J Neuroradiol 2007, 28:411-420.
104. Bammer R., Auer M., Keeling S.L., et al. Diffusion tensor imaging using single-shot SENSE-EPI. Magn Reson Med 2002, 48:128-136.
105. Frank L.R. Anisotropy in high angular resolution diffusion-weighted MRI. Magn Reson Med 2001, 45:935-939.
106. Assaf Y., Ben-Bashat D., Chapman J., et al. High b-value q-space analyzed diffusion-weighted MRI: application to multiple sclerosis. Magn Reson Med 2002, 47:115-126.
107. Frank L.R. Characterization of anisotropy in high angular resolution diffusion-weighted MRI. Magn Reson Med 2002, 47:1083-1099.
108. Alexander D.C., Pierpaoli C., Basser P.J., et al. Spatial transformation of diffusion tensor magnetic resonance images. IEEE Trans Med Imaging 2001, 20:1131-1139.
109. Park H.J., Kubicki M., Shenton M.E., et al. Spatial normalization of diffusion tensor MRI using multiple channels. Neuroimage 2003, 20:1995-2009.